Polypharmacy is a major issue for individuals with intellectual disability. There have been many proposed definitions of polypharmacy, including using five or more medications. Individuals with intellectual disability are at increased risk for polypharmacy given the presence of multiple co-morbidities such as mental health and neurologic conditions. Commonly prescribed medications for patients with intellectual disability include antipsychotics, anti-epileptics, and antidepressants. Common adverse effects of these medications include sedation, insomnia, nausea, constipation, and weight gain. Importantly, there are strategies that can help reduce polypharmacy and its negative effects, including medication reconciliation tools and processes such as the Systematic Tool to Reduce Inappropriate Prescribing (STRIP).
KeywordsPolypharmacy Psychotropic drugs Intellectual disability
- 1.Deb S, Farmah BK, Arshad E, Deb T, Roy M, Unwin GL. The effectiveness of aripiprazole in the management of problem behaviour in people with intellectual disabilities, developmental disabilities and/or autistic spectrum disorder – a systematic review. Res Dev Disabil. 2014;35:711–25.CrossRefGoogle Scholar
- 10.Arvio M, Sillanpaa M. Prevalence, aetiology, and comorbidity of severe and profound intellectual disability (SPID) in Finland. J Intellect Disabil Res. 2004;48:429.Google Scholar
- 13.Mahan S, Holloway J, Bamburg JW, Hess JA, Fodstad JC, Matson JL. An examination of psychotropic medication side effects: Does taking a greater number of psychotropic medications from different classes affect presentation of side effects in adults with ID? Res Dev Disabil. 2010;31:1561–9.CrossRefGoogle Scholar
- 14.Jackson C, Makin S, Marson A, Kerr M. Pharmacological interventions for epilepsy in people with intellectual disabilities. Cochrane Database Syst Rev. 2015;3(9):CD005399.Google Scholar
- 19.Ayub M, Saeed K, Munshi TA, Naeem F. Clozapine for psychotic disorders in adults with intellectual disabilities. Cochrane Database Syst Rev. 2015;23(9):Cd010625.Google Scholar
- 22.Special Olympics International. MedFest medication watch list. Retrieved from http://resources.specialolympics.org/Taxonomy/Health/_Catalog_of_MedFest.aspx.
- 26.Kalachnik JE, Sprague RL. The dyskinesia identification system condensed user scale (DISCUS): relability, validity, and a total score cut-off for mentally ill and mentally retarded populations. J Clin Psychiatry. 1993;49:177–89.Google Scholar